Phillip Schroth

534 total citations
16 papers, 407 citations indexed

About

Phillip Schroth is a scholar working on Hematology, Genetics and Cognitive Neuroscience. According to data from OpenAlex, Phillip Schroth has authored 16 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 3 papers in Genetics and 3 papers in Cognitive Neuroscience. Recurrent topics in Phillip Schroth's work include Hemophilia Treatment and Research (9 papers), Platelet Disorders and Treatments (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Phillip Schroth is often cited by papers focused on Hemophilia Treatment and Research (9 papers), Platelet Disorders and Treatments (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Phillip Schroth collaborates with scholars based in United States, Austria and United Kingdom. Phillip Schroth's co-authors include Bruce M. Ewenstein, Peter W. Collins, Kathleen Casey, Sandor Fritsch, Victor S. Blanchette, Gerald Spotts, Sven Björkman, Myungshin Oh, Kathelijn Fischer and Edward Ritvo and has published in prestigious journals such as Blood, Journal of the American Academy of Child & Adolescent Psychiatry and The American Journal of Cardiology.

In The Last Decade

Phillip Schroth

16 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip Schroth United States 8 253 69 66 49 40 16 407
Stephen Wright United Kingdom 5 59 0.2× 28 0.4× 36 0.5× 53 1.1× 17 0.4× 9 179
Carlotta Canavese Italy 11 43 0.2× 20 0.3× 19 0.3× 86 1.8× 54 1.4× 33 340
Mary C. Kral United States 8 143 0.6× 188 2.7× 16 0.2× 62 1.3× 5 0.1× 16 302
Lauren A. Williams Canada 5 131 0.5× 58 0.8× 28 0.4× 11 0.2× 5 0.1× 8 418
Daniel Gustavo Politis Argentina 5 64 0.3× 50 0.7× 41 0.6× 33 0.7× 8 0.2× 46 191
Amira Masri Jordan 11 22 0.1× 37 0.5× 59 0.9× 152 3.1× 44 1.1× 59 403
Yuan Ai China 10 87 0.3× 24 0.3× 83 1.3× 77 1.6× 9 0.2× 25 260
Ashajyothi M. Siddappa United States 6 262 1.0× 161 2.3× 16 0.2× 18 0.4× 24 0.6× 12 472
Eleftherios Kontopoulos Greece 9 42 0.2× 64 0.9× 12 0.2× 184 3.8× 29 0.7× 14 314
Samantha McCann United Kingdom 6 65 0.3× 26 0.4× 45 0.7× 16 0.3× 9 0.2× 13 263

Countries citing papers authored by Phillip Schroth

Since Specialization
Citations

This map shows the geographic impact of Phillip Schroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Schroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Schroth more than expected).

Fields of papers citing papers by Phillip Schroth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Schroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Schroth. The network helps show where Phillip Schroth may publish in the future.

Co-authorship network of co-authors of Phillip Schroth

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Schroth. A scholar is included among the top collaborators of Phillip Schroth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Schroth. Phillip Schroth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Björkman, Sven, Myungshin Oh, Gerald Spotts, et al.. (2011). Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight. Blood. 119(2). 612–618. 160 indexed citations
2.
Oh, Myungshin, Sven Björkman, Phillip Schroth, et al.. (2010). Use of a Population Pharmacokinetic Model of ADVATE In Pediatric and Adult Patients with Hemophilia A Permits Limited Blood Sampling for Individual Dose Tailoring.. Blood. 116(21). 1416–1416. 2 indexed citations
3.
Oh, Myungshin, Sven Björkman, Phillip Schroth, et al.. (2009). Population Pharmacokinetic Model of ADVATE in Pediatric and Adult Patients with Hemophilia A.. Blood. 114(22). 3492–3492. 1 indexed citations
4.
Shapiro, Amy D., Ralph A. Gruppo, Ingrid Pabinger, et al.. (2009). Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia A. Expert Opinion on Biological Therapy. 9(3). 273–283. 28 indexed citations
5.
Shapiro, Amy, Ingrid Pabinger, Michael D. Tarantino, et al.. (2008). Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: Efficacy and safety of Advate in previously treated patients. Thrombosis and Haemostasis. 100(8). 217–223. 52 indexed citations
6.
Collins, Peter W., Kathelijn Fischer, Victor S. Blanchette, et al.. (2008). Effect of Normal Variation in Factor VIII Pharmacokinetics on Prophylactic Dosing Requirements in Severe Classical Hemophilia.. Blood. 112(11). 1222–1222. 2 indexed citations
7.
Fischer, Kathelijn, Peter W. Collins, Jan Astermark, et al.. (2007). Internal and External Determinants of Bleeding Patterns on Prophylaxis for Severe Haemophilia A.. Blood. 110(11). 1145–1145. 6 indexed citations
8.
Collins, Peter W., Victor S. Blanchette, Kathelijn Fischer, et al.. (2006). Clinical Implications of Pharmacokinetic Variables in the Management of Patients with Severe Hemophilia A.. Blood. 108(11). 1041–1041. 2 indexed citations
9.
Blanchette, Victor S., Fernando Hernández, Anastassios D. Retzios, et al.. (2004). Characterization of the Pharmacokinetics of rFVIII in Young Pre-School Children with Hemophilia, Including an Analysis of the Influence of Age and Body Weight.. Blood. 104(11). 3084–3084. 5 indexed citations
10.
Hershman, Jerome M., et al.. (1991). Dietary Restriction on Serum Thyroid Hormone Levels. The American Journal of the Medical Sciences. 301(5). 310–313. 13 indexed citations
11.
Mason-Brothers, A, Edward Ritvo, Barry H. Guzé, et al.. (1987). Pre-, Peri-, and Postnatal Factors in 181 Autistic Patients from Single and Multiple Incidence Families. Journal of the American Academy of Child & Adolescent Psychiatry. 26(1). 39–42. 39 indexed citations
12.
Ritvo, Edward, B. J. Freeman, Arthur Yuwiler, et al.. (1984). Study of fenfluramine in outpatients with the syndrome of autism. The Journal of Pediatrics. 105(5). 823–828. 41 indexed citations
13.
Fawzy, Fawzy I., David K. Wellisch, Robert Pasnau, et al.. (1984). Psychotherapy as an adjunct to supervised fasting for obesity. Psychosomatics. 25(11). 821–829. 2 indexed citations
14.
Crandall, Barbara F., et al.. (1983). Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.. PubMed. 138(4). 524–30. 21 indexed citations
15.
Weidmann, P, David J. Hirsch, Morton H. Maxwell, Ronald Okun, & Phillip Schroth. (1974). Plasma renin and blood pressure during treatment with methyldopa. The American Journal of Cardiology. 34(6). 671–676. 31 indexed citations
16.
Schroth, Phillip, et al.. (1972). PLASMA ERYTHROPOIETIC ACTIVITY IN PATIENTS ON CHRONIC DIALYSIS WITH OR WITHOUT KIDNEYS. ASAIO Journal. 18(1). 291–294. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026